Tampa General Hospital

NexVal CenterResearch CenterTreats Aortic, Mitral, and Tricuspid valves

AI Description

Tampa General Hospital’s Minimally Invasive Valve Program uses a multidisciplinary heart team of interventional cardiologists, cardiothoracic surgeons and other specialists to evaluate and treat valve disease with catheter-based procedures. Care includes transcatheter aortic valve replacement (TAVR/TAVI), transcatheter mitral and tricuspid valve repair, tricuspid valve implantation, and surgical valve repair or replacement using mechanical or biological valves, including the Ross procedure.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

1 Tampa General Cir
Tampa, FL 33606

Clinical Trials

Active, not recruiting

TRICAV-I

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Public sites
34
Start date
Jul 23, 2024
Upcoming

TRICAV-II

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

Public sites
31
Start date
Aug 1, 2026
Recruiting

RESTORE

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Public sites
65
Start date
Feb 6, 2025
Recruiting

APOLLO

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Public sites
71
Start date
Oct 23, 2017
Recruiting

CHOICE-MI

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

Public sites
9
Start date
Nov 1, 2020

Nearby Centers